Posts

New gene therapy may ‘turn off’ asthma

/0 Comments/in /by

The findings showed that the single treatment may give life-long protection from asthma as well as those who have severe allergies to peanuts, bee venom, shell fish and other substances by de-sensitising the immune system to tolerate the protein.

Researchers have developed a new gene therapy that may help to ‘turn-off’ the immune response which causes allergic reaction such as asthma, or potentially lethal food allergies, researchers have found.

“When someone has an allergy or asthma flare-up, the symptoms they experience results from immune cells reacting to protein in the allergen,” said Ray Steptoe, Associate Professor at the University of Queensland in Australia.

The findings showed that the single treatment may give life-long protection from asthma as well as those who have severe allergies to peanuts, bee venom, shell fish and other substances by de-sensitising the immune system to tolerate the protein.

“The challenge in asthma and allergies is that these immune cells, known as T-cells, develop a form of immune ‘memory’ and become very resistant to treatments,” Steptoe said.

“We have now been able ‘wipe’ the memory of these T-cells in animals with gene therapy, de-sensitising the immune system so that it tolerates the protein,” he added.

For the study, detailed in the journal JCI Insight, the team took blood stem cells, and inserted a gene which regulated the allergen protein and put that into the recipients.

“Those engineered cells produced new blood cells that express the protein and target specific immune cells, ‘turning off’ the allergic response,” Steptoe noted.

The eventual goal would be a single injected gene therapy, that is simpler and safer which could be used across a wide cross-section of affected individuals, he said.

Source: http://indianexpress.com/article/lifestyle/health/new-gene-therapy-may-turn-off-asthma-4690204/

iMedWorks Ask Platform Links below:

1. Get a Medical Second Opinion
2. Search doctors and Request Appointment

Gene therapy could restore hand function after spinal cord injury

/0 Comments/in /by

Researchers have tested a new gene therapy that has shown potential to help people with spinal cord injuries to re-learn skilled hand movements. People with spinal cord injury often lose the ability to perform everyday actions that require coordinated hand movements such as writing, holding a toothbrush or picking up a drink.

In the study published in the journal Brain, researchers tested the new gene therapy on rats for regenerating damaged tissue in the spinal cord that could be switched on and off using a common antibiotic. “What is exciting about our approach is that we can precisely control how long the therapy is delivered by using a gene ‘switch’. This means we can hone in on the optimal amount of time needed for recovery,” said Elizabeth Bradbury, Professor at King’s College London.

“Gene therapy provides a way of treating large areas of the spinal cord with only one injection, and with the switch we can now turn the gene off when it is no longer needed,” she added.

After a traumatic spinal injury, dense scar tissue forms which prevents new connections being made between nerve cells. The gene therapy causes cells to produce an enzyme called chondroitinase which can break down the scar tissue and allow networks of nerve cells to regenerate.

The researchers gave the gene therapy to rats with spinal injuries that closely mimicked the kind of human spinal injuries that occur after traumatic impacts such as car crashes or falls. “We found that when the gene therapy was switched on for two months the rats were able to accurately reach and grasp sugar pellets,” explained Emily Burnside from King’s College London.

“We also found a dramatic increase in activity in the spinal cord of the rats, suggesting that new connections had been made in the networks of nerve cells,” she noted.

However, the researchers had to overcome a problem with the immune system recognising and removing the gene switch mechanism.

To get around this, they added a “stealth gene” which hides the gene switch from the immune system. The gene therapy is not yet ready for human trials, the researchers said.

Source: https://indianexpress.com/article/lifestyle/health/gene-therapy-could-restore-hand-function-after-spinal-cord-injury-5222196/

(Picture for representation)

iMedWorks Ask Platform Links below:

1. Get a Medical Second Opinion
2. Search doctors and Request Appointment